// COMPANY
VitriVax
SECTOR BIOTECHMENTIONS 3LAST SEEN NOVEMBER 18, 2026
// OVERVIEW
Biotech company specializing in vaccine development.
Discussed in
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
funding·PitchBook News·NOVEMBER 19, 2026
“VitriVax... raised an $87 million Series C led by F-Prime, NEA, RA Capital Management and Sanofi Ventures.”
Source→02
mention·Axios Pro Rata·NOVEMBER 18, 2026
“Hone Health $228m, Marrow $120m, VitriVax $87m, KKR's $5.7b Integer take-private”
Source→03
funding·Axios Pro Rata·NOVEMBER 18, 2026
“VitriVax $87m”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.